First nosocomial infections in children supported by veno-arterial extracorporeal membrane oxygenation (VA-ECMO)

被引:8
|
作者
Cousin, Vladimir L. L. [1 ]
Rodriguez-Vigouroux, Robert [2 ]
Karam, Oliver [3 ]
Rimensberger, Peter [1 ]
Posfay-Barbe, Klara M. M. [4 ]
机构
[1] Geneva Univ Hosp, Dept Pediat Gynecol & Obstet, Pediat Intens Care Unit, Geneva, Switzerland
[2] Geneva Univ Hosp, Geneva, Switzerland
[3] Yale Sch Med, Dept Pediat, Sect Pediat Crit Care, New Haven, CT USA
[4] Geneva Univ Hosp, Dept Pediat Gynecol & Obstet, Pediat Infect Dis Unit, Geneva, Switzerland
关键词
ECMO; PICU; Infection; Nosocomial; PEDIATRIC-PATIENTS; LIFE-SUPPORT;
D O I
10.1186/s12887-023-03908-3
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
BackgroundVeno-arterial Extracorporeal Membrane Oxygenation (VA-ECMO) is a standard procedure for patient with refractory shock in Pediatric Intensive Care Unit (PICU). There is a paucity of data on the time relationship between VA-ECMO support, nosocomial infection occurrence, and PICU length of stay (LOS). The aim of this study was to determine the characteristics and impact of ECMO-related infections.MethodsThis is a retrospective study from 01/2008 to 12/2014, enrolling children with a VA-ECMO support for > 6 h. We recorded the first PICU infection during the VA-ECMO run, defined as a positive microbiological sample with clinical signs of infection or clinical signs of severe infection without positive sample.ResultsDuring the study period, 41 patients (25/41 male) were included, with a median age of 41.2 months (IQR 12.9-89.9) and a 53% mortality rate. Median time on VA-ECMO was 4.2 d (IQR 2-7.1), median PICU LOS was 14.7 d (IQR 4,7-26,9). Overall, 34% patients developed an infection, with an incidence of 60/1000 VA-ECMO days. Median time to first infection was 4 d (IQR 3-5), with Pseudomonas spp. being the most commonly detected microorganism (42%). Infected sites were ventilator-associated pneumonia (9/14), sternotomy infection (2/14), bloodstream (2/14) and urinary tract infections (1/14). Longer VA-ECMO support (> 5 d) (OR 5.9 (CI 95% 1.4-24.6; p = 0.01) and longer PICU stay (> 14 d) (OR 12 (95% CI 2.2-65.5; p = 0.004) were associated with infection.ConclusionIn this single-center study, we underlined the high proportion and early occurrence of infections in patient on VA-ECMO, mostly in the first week. As infection was an early event, it may prolong the duration of VA-ECMO support and PICU LOS. Further research is needed to better understand the impact of infections on VA-ECMO and develop prevention strategies.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] The Influence of a Dedicated and Protocolized Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) Strategy on Patient Outcomes: A Before and After Study
    Williams, R.
    Coffin, S.
    Derryberry, S.
    Djunaidi, M.
    Shah, A.
    Huang, S.
    McGrane, S.
    Cropsey, C.
    Henson, C.
    Costello, W.
    Kennedy, J.
    Haddad, E.
    Danter, M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S350 - S351
  • [22] Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) as a bridge to a mechanical ventricular assist device (VAD) as a bridge to transplantation (BTT)
    Samadi, Behnoosh
    Buscher, Hergen
    Nair, Priya
    AUSTRALIAN CRITICAL CARE, 2016, 29 (02) : 122 - 122
  • [23] The Characteristics and Outcome of Patients Receiving Veno-venous and Veno-arterial Extracorporeal Membrane Oxygenation (VV-ECMO and VA-ECMO) in a Tertiary Hospital in Hong Kong
    Ng, W. T.
    Chan, K. M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 43 - 44
  • [24] Application of New Generation Rotary Pumps and Oxygenators for Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) for Refractory Cardiogenic Shock (RCS)
    Soleimani, B.
    Manoskey, A.
    Baer, L.
    Stephenson, E. R.
    Brehm, C.
    Pae, W. E.
    El-Banayosy, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (04): : S256 - S256
  • [25] SEX DIFFERENCES IN OUTCOMES AMONG PATIENTS UNDERGOING VENO-ARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION (VA-ECMO) PROCEDURE: A RETROSPECTIVE COHORT STUDY
    Beshai, Rafail
    Daneshvar, Maziyar
    Weinberg, Howard M.
    Elias, Tony
    Saad, Marwan
    Dani, Sourbha S.
    Shaikh, Hafeza
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 2365 - 2365
  • [26] Application of New Generation Rotary Pumps and Oxygenators for Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) for Refractory Cardiogenic Shock (RCS)
    Soleimani, B.
    Brehm, C.
    Wallace, S.
    Eleuteri, K.
    Nunez, A.
    Stephenson, E.
    Pae, W. E.
    El-Banayosy, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04): : S211 - S211
  • [27] Veno-Arterial Extracorporeal Membrane Oxygenation Support (VA-ECMO) in acute coronary syndrome complicated by cardiogenic shock. Clinical outcomes
    Al Abbasi, B.
    Torres, P.
    Grajeda, E.
    Dayanand, P.
    Qader, M. Abdul
    Job, R.
    Avila, K.
    Pino, J. E.
    Ghumman, W.
    Chait, R.
    Mirza, S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 207 - 207
  • [28] Non-elective thoracic surgery in patients supported by veno-venous (VV) or veno-arterial (VA) extracorporeal membrane oxygenation (ECMO)
    Ried, Michael
    Sommerauer, Laura
    Markowiak, Till
    Wiesner, Sigrid
    Mueller, Thomas
    Philipp, Alois
    Unterbuchner, Christoph
    Creutzenberg, Marcus
    Lunz, Dirk
    Hofmann, Hans-Stefan
    CURRENT CHALLENGES IN THORACIC SURGERY, 2023, 5
  • [29] TRENDS AND PREDICTORS OF MORTALITY IN PATIENTS ON VENO-ARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION(VA ECMO) FOR CARDIOGENIC SHOCK
    Syed, Moinuddin
    Khan, Muhammad
    Agrawal, Pratik
    Osman, Mohammed
    Zahid, Salman
    Balla, Sudarshan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 819 - 819
  • [30] Upgrade from veno-arterial (VA) to veno-veno-arterial (VVA) extracorporeal membrane oxygenation (ECMO) in a patient with severe Harlequin syndrome
    Brand M.
    Christ M.
    Dierschke W.
    Amirie S.
    Roeing J.
    Grett M.
    Beko M.
    Breker I.
    Wennemann R.
    Trappe H.-J.
    Der Kardiologe, 2017, 11 (2): : 121 - 124